Does LISINOPRIL Cause Hypertransaminasaemia? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hypertransaminasaemia have been filed in association with LISINOPRIL (Lisinopril). This represents 0.0% of all adverse event reports for LISINOPRIL.
5
Reports of Hypertransaminasaemia with LISINOPRIL
0.0%
of all LISINOPRIL reports
1
Deaths
4
Hospitalizations
How Dangerous Is Hypertransaminasaemia From LISINOPRIL?
Of the 5 reports, 1 (20.0%) resulted in death, 4 (80.0%) required hospitalization.
Is Hypertransaminasaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LISINOPRIL. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does LISINOPRIL Cause?
Angioedema (5,370)
Drug hypersensitivity (3,779)
Cough (2,527)
Completed suicide (2,246)
Drug ineffective (2,208)
Acute kidney injury (2,022)
Dyspnoea (1,856)
Dizziness (1,758)
Hypotension (1,750)
Fatigue (1,549)
What Other Drugs Cause Hypertransaminasaemia?
METHOTREXATE (436)
ACETAMINOPHEN (326)
PACLITAXEL (318)
CARBOPLATIN (304)
PEMBROLIZUMAB (231)
ATORVASTATIN (207)
CYCLOPHOSPHAMIDE (202)
PREDNISONE (198)
GEMCITABINE (196)
DEXAMETHASONE (169)
Which LISINOPRIL Alternatives Have Lower Hypertransaminasaemia Risk?
LISINOPRIL vs LISOCABTAGENE MARALEUCEL
LISINOPRIL vs LITHIUM
LISINOPRIL vs LIXISENATIDE
LISINOPRIL vs LOBAPLATIN
LISINOPRIL vs LOFEXIDINE